Labetuzumab (Anti-CEACAM5 / CEA / CD66e), 1mg*5

Labetuzumab (Anti-CEACAM5 / CEA / CD66e), 1mg*5

Anti-CEACAM6 / CD66c (NEO-201), 1mg

Anti-CEACAM6 / CD66c (NEO-201), 1mg

Labetuzumab (Anti-CEACAM5 / CEA / CD66e), 1mg*25

27.059,41 RON
SKU
SKM_A2638_1mg*25

Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.

Mai multe informatii
Price 22.739,00 RON (preturile sunt fara TVA)
Description

Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.